Verrica Pharmaceuticals Inc. Proceeds from Issuance of Debt
Verrica Pharmaceuticals Inc. (VRCA) reported Proceeds from Issuance of Debt of $35.00 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2020-11-09
- Verrica Pharmaceuticals Inc. proceeds from issuance of debt for the quarter ending 2020-09-30 was $0.00.
- Verrica Pharmaceuticals Inc. proceeds from issuance of debt for the quarter ending 2020-06-30 was $0.00.
- Verrica Pharmaceuticals Inc. proceeds from issuance of debt for the quarter ending 2020-03-31 was $35.00M.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 9 month |
|---|---|---|---|
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $35.00M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $35.00M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $35.00M 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |